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HSP90 protectionWe are here showing that peripheral mononuclear blood cells (PBMC) from cystic ﬁbrosis (CF) patients contain
almost undetectable amounts ofmature 170 kDa CF-transmembrane conductance regulator (CFTR) and a highly
represented 100 kDa form. This CFTR protein, resembling the form produced by calpain digestion and present,
although in lower amounts, also in normal PBMC, is localized in cytoplasmic internal vesicles. These observa-
tions are thus revealing that the calpain-mediated proteolysis is largely increased in cells from CF patients. To
characterize the process leading to the accumulation of such split CFTR, FRT cells expressing the F508del-CFTR
mutated channel protein and human leukaemic T cell line (JA3), expressingwild type CFTRwere used. In in vitro
experiments, the sensitivity of themutated channel to theprotease is identical to that of thewild type,whereas in
Ca2+-loaded cells F508del-CFTR is more susceptible to digestion. Inhibition of intracellular calpain activity
prevents CFTR degradation and leads to a 10-fold increase in the level of F508del-CFTR at the plasmamembrane,
further indicating the involvement of calpain activity in the maintenance of very low levels of mature channel
form. The higher sensitivity to calpain of the mutated 170 kDa CFTR results from a reduced afﬁnity for HSP90
causing a lower degree of protection from calpain digestion. The recovery of HSP90 binding capacity in F508del-
CFTR, following digestion, explains the large accumulation of the 100 kDa CFTR form in circulating PBMC fromCF
patients.-associated degradation; CFTR,
F, cystic ﬁbrosis; C.I.2, calpain
+39 010 518343.
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It is well established that cystic ﬁbrosis transmembrane conduc-
tance regulator (CFTR) is a cAMP regulated chloride channel located at
the apical surface of the cell [1–3]. Its level and functional location is
the result of a complex multistep process involving synthesis,
maturation and correct folding of the protein [4,5], ﬁnally undergoing
targeting at the apical plasma membrane [6–9].
Deletion of Phe508 in CFTR (F508del-CFTR) is the major cause
of cystic ﬁbrosis (CF) [10]. Due to an inefﬁcient folding, a large num-
ber of the mutated protein molecules is destroyed by the ubiquitin
proteasome system as part of the endoplasmic reticulum (ER)-
associated quality control (ERAD) [11]. In addition, structurally
destabilized membrane F508del-CFTR molecules that have escaped
the ERAD can be removed by lysosomal degradation in the course
of the plasma membrane endocytic recycling of CFTR [12–15]. As aresult of the action of both ERAD and peripheral quality control, a very
low amount of F508del-CFTR is functionally present at the plasma
membrane and an excess of nonfunctional protein remains trapped
within the cell [15]. Furthermore, using an in vitro biochemical assay, it
has been observed that the cytoplasmic domain of both wild type and
F508del-CFTR, expressed in rabbit reticulocyte lysates, undergoes
proteolytic degradation by a still unidentiﬁed cysteine proteinase [16].
Since misfolding is the intrinsic molecular defect responsible
for the instability of the mutated F508del-CFTR, several efforts were
made to develop chemical compounds, usually deﬁned as folding cor-
rectors, capable to restore a proper CFTR molecular folding thus being
potentially useful as therapeutic devices in cystic ﬁbrosis [17–21].
These compounds, although capable to deliver only small amounts of
functional F508del-CFTR at the plasma membrane, resulted to be very
useful in providing new information concerning the mechanisms
involved in the maturation of CFTR. Since the conformational defect
of F508del-CFTR was shown to be temperature-dependent, the
processing block in ER could be, at least partially, overcome reducing
the temperature at 27 °C [22]. The observation that, as a consequence
of rescuing F508del-CFTR by low temperature and by correctors, a
decrease in the altered intracellular [Ca2+] occurs [23], could suggest
that an additional proteolytic system is involved in the regulation of
CFTR trafﬁcking.
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addition to the native 170 kDa and to the immature 150 kDa CFTR forms,
an additional one with a Mr of 100 kDa was also present. This 100 kDa
CFTR formhasneverbeen identiﬁedbeforeamong thevariousCFTR forms
[24]. However, similar 100 kDa CFTR fragment has been obtained by
incubation of the membrane-bound channel protein with trypsin,
indicating that CFTR exposes, in the inner surface of the plasma
membrane, a sequence highly accessible to proteases [24,25]. The
calpain-mediated proteolytic origin of the 100 kDa CFTR form has been
supported by the increase in the native 170 kDa form, localized at the
plasma membrane, observed in cells grown for two cell cycles in the
presence of a synthetic inhibitor of the protease (C.I.2) or in cells over-
expressing calpastatin, the natural protein inhibitor of calpain [24]. Based
on the molecular mass of the fragments, produced by proteolysis,
the calpain site of cleavage can be located between the ﬁrst nucleotide
binding domain (NBD1) and the regulatory domain. However, the
fragments, present in the split protein, remain associated to membranes
in close contact each other. Of relevance was the ﬁnding that, also in
peripheralmononuclear blood cells (PBMC) fromhealthy donors, the 100
kDa CFTR form not only was present, but its level was higher than that
of the native channel protein. Thus, degradation of plasma membrane
CFTR appears to be normally operating in physiological conditions.
We are herewith showing that, in cells expressing F508del-CFTR,
also the mutated channel protein undergoes an identical calpain-
mediated limited proteolysis which occurs however at a much higher
extent producing an even larger excess of the 100 kDa CFTR form. This
calpain-mediated F508del-CFTR degradation can thus be considered
involved in themaintenance of a very low level of themutated chloride
channel at the plasma membrane. In accordance, data are presented
demonstrating that inhibition of calpain restores large amounts of
F508del-CFTR at the plasma membrane.
We are suggesting that, beside ERAD and the peripheral quality
control are responsible for the removal of misfolded channel
molecules, degradation by calpain of the mutated F508del-CFTR,
present at the plasma membrane, is an additional mechanism for the
modulation of the channel protein level at its functional location.
Accordingly, the Ca2+-dependent proteolysis can be considered as a
promising target for CF therapeutic treatment.
2. Materials and methods
2.1. Materials
Nutrient mixture F-12 Coon's modiﬁcation, RPMI1640, leupeptin,
calpain inhibitor 2 (C.I.2), calcium ionophore A23187, Triton® X-100,
dibutyryl cAMP and MG132 were purchased from Sigma-Aldrich.
Foetal bovine serum (FBS), penicillin, streptomycin and L-glutamine
were obtained from EuroClone. Zeocinwas purchased from Invivogen.
Geneticin was obtained from Invitrogen. 4-(2-aminoethyl) benzene-
sulfonylﬂuoride (AEBSF) was obtained from Calbiochem. ECL AD-
VANCE® Detection System was obtained from GE Healthcare. t-Boc-
Leu-Met-CMAC ﬂuorogenic calpain substrate was purchased from
Molecular Probes (Invitrogen). Corr-4a was kindly provided Dr. L.J.
Galietta, Molecular Genetics Laboratory, Giannina Gaslini Institute
Genova, Italy. Human erythrocyte calpain was isolated and assayed as
reported in [26]. One unit of calpain activity is deﬁned as the amount
that releases 1 nmol/h of free α-amino groups under the speciﬁed
conditions [27]. HSP90 was puriﬁed from rat brain as reported in [28].
Anti-CFTR monoclonal antibody (clone M3A7) was purchased
from Millipore. Anti-HSP90 monoclonal antibody was obtained from
BD Biosciences.
2.2. Cell culture
Fisher rat thyroid (FRT) cell line expressing humanwild type (WT)
or F508del-CFTR was cultured at 37 °C (5% CO2) with Coon's F-12growth medium, containing 10% FBS, 10 U/ml penicillin, 100 μg/ml
streptomycin, 4 mM L-glutamine and 0.6 mg/ml zeocin. FRT cell line
was kindly provided by Dr. L.J. Galietta, Molecular Genetics Labora-
tory, Giannina Gaslini Institute Genova, Italy. JA3 cells, a human
leukaemic T cell line, were cultured at 37 °C (5% CO2) with RPMI1640
growth medium, containing 10% FBS, 10 U/ml penicillin, 100 μg/ml
streptomycin, 4 mM L-glutamine.
2.3. Isolation of the total membrane fraction
FRT cells expressing WT or F508del-CFTR, JA3 cells (collected
during the growing log-phase) and PBMC isolated as previously
reported [29], were washed three times with ice-cold PBS solution.
The total membrane fraction was isolated following lysis of 25×106
cells in 1 ml buffer A (1 mMEDTA, pH 7.0), containing 5 μg leupeptin and
10 μg AEBSF by three cycles of freezing and thawing, followed by
centrifugation at 60000×g for 10 min at 4 °C. The particulate material
(totalmembrane fraction)waswashed three times in buffer A andﬁnally
suspended in 0.5 ml of the same solution. The protein concentration
was determined following the Lowry procedure, and aliquots (50 μg
protein) were diluted in 30 μl Laemmli SDS-PAGE loading solution,
incubated at 37 °C for 30 min and submitted to 6% SDS-PAGE [30].
2.4. Native electrophoresis
The total membrane fraction, prepared as described above, from
JA3 cells and PBMC from control donors and CF patients (F508del-
CFTR homozygotes), was solubilized in 100 μl 0.35 M Tris/HCl pH 9.0,
containing 0.5 M KCl and 0.1% Triton® X-100. The samples were then
loaded on to a 0.8% agarose gel as described in ref. [24].
2.5. Isolation of plasma and intracellular membranes
The total membrane fraction (0.5 ml) isolated from JA3 cells and
from FRT cells expressing WT or F508del-CFTR was fractionated on a
discontinuous sucrose density gradient as described in [24].
2.6. Immunoprecipitation and immunoblotting
Plasma membranes, isolated from JA3 cells and from FRT cells
expressing F508del-CFTR both collected during the growing log-phase,
were solubilized in 300 μl buffer A containing 0.15 M NaCl and 1%
Triton® X-100. Aliquots of HSP90 puriﬁed from rat brain [28] were then
added to the membrane suspensions. The mixtures, pre-treated with
protein G-Sepharose, were incubated over night with 2 μg of anti-CFTR
antibody (clone M3A7) at 4 °C. Protein G-Sepharose was then added to
the sampleswhichwere incubated for anadditional 1 hwith continuous
gentle shaking. The immunocomplexes were washed three times with
buffer A, incubated at 37 °C in SDS-PAGE loading buffer for 30 min and
submitted to SDS-PAGE (6% gels) [30]. Proteinswere then transferred to
nitrocellulosemembranes (Bio-Rad) by electroblotting [31] and probed
with the speciﬁc mAb, followed by a peroxidase-conjugated secondary
antibody as described in [32]. The immunoreactive material was
developed with ECL ADVANCE® detection system, detected with a
Bio-Rad Chemi Doc XRS apparatus and quantiﬁed using the Quantity
One 4.6.1 software (Bio-Rad Laboratories).
2.7. Confocal microscopy imaging and ﬂuorescence quantiﬁcation
Cells (105) were ﬁxed and permeabilized by the Triton/parafor-
maldehyde method, as described in ref. [33]. Cells were treated with
10 μg/ml CFTR antibody (M3A7) diluted in PBS solution, containing
5% (v/v) FBS. After incubation for 3 h at 25 °C, cells were washed three
timeswith PBS solution and treatedwith 4 μg/ml chicken anti-(mouse
IgG) Alexa Fluor® 488-conjugate secondary antibody (Molecular
Probes) for 1 h. Images were collected using a Bio-Rad MRC1024
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aperture 1.4. Sequential acquisitions were performed to avoid cross-
talk between colour channels. The ﬂuorescence intensity in each
image was quantiﬁed using LaserPix software (Bio-Rad) following the
procedure described in ref. [34].
2.8. Assay of intracellular calpain activity
FRT cells expressingWT or F508del-CFTR (2×104 cells) grown on a
96-well microplate or, alternatively, JA3 cells (105) were incubated for
30 min at 37 °C in 100 μl buffer B (10 mM Hepes pH 7.4, 0.14 M NaCl,
5 mM KCl, 5 mM glucose) containing 50 μM t-Boc-Leu-Met-CMAC,
the ﬂuorogenic substrate, in the absence or presence of 20 μM
dibutyryl cAMP, known to favour the protease activation by removal
of calpastatin from cytosol [35,36]. Cells were then washed twice with
buffer B in order to remove substrate excess and after addition of
100 μl buffer B containing 2 mM CaCl2 and, alternatively, 0.1 or 0.5 μM
calcium ionophore A23187. Calpain activity was assayed after 10 min
of incubation and expressed as the increase in ﬂuorescence detected
at 37 °C with a Mithras LB 940 plate reader (Berthold Technologies).
The excitation/emission wavelengths were 355/485 nm, respectively.
3. Results
3.1. Characterization of the CFTR forms in growing cells expressing the
wild type and Phe508 deleted species
In peripheral mononuclear blood cells (PBMC) from healthy
subjects three major CFTR bands have been previously identiﬁed
[24]. A ﬁrst one, corresponding to the native mature 170 kDa form
(band C), a second one of 150 kDa, generally indicated as an immature
channel form (band B) and a third one of a molecularmass of 100 kDa,
characterized as a fragment produced by a calpain-mediated limited
proteolysis [24]. At difference, in PBMC from cystic ﬁbrosis (CF)
patients, the 170 kDa and the 150 kDa forms were represented by two
very faint bands, whereas the 100 kDa CFTR fragment was the most
largely detectable form exceeding in amount 3-fold to 4-fold the level
present in control PBMC (Fig. 1A and B). These ﬁndings are indicating
that, in PBMC of CF patients, the mutated F508del-CFTR undergoes to
calpain-mediated digestion at a much higher extent in comparison
with controls, thereby conﬁrming the constitutive occurrence of this
degradative process. To further explore the role of calpain digestion
on the functional level of F508del-CFTR and to overcome the
experimental difﬁculties derived by the use of nongrowing cells and
particularly by the very low level of detectable mutated channel form,
we have utilized FRT cells expressing both wild type or F508del-CFTR
and a human leukaemic T cell line (JA3 cells) constitutively expressing
the wild type CFTR. These clones were selected because in each one
the native 170 kDa or the split 100 kDa formswere either both present
or one of the two was highly predominant [24], thereby allowing
more precise comparative studies. In Fig. 1 the immunoblot analyses
performed on total membrane fraction, isolated from the three cell
types, are also reported. In FRT cells, probably due to a large
expression of the wild type CFTR, most of the channel protein was
present in the 170 kDa form and only low amounts of the 150 kDa
CFTR and 100 kDa forms were detectable (Fig. 1C). In the same cellFig. 1. CFTR forms in PBMC, FRT and JA3 cells. Aliquots (20 μg) of the total membrane
fraction (see Materials and methods), prepared from normal (A) or CF (B) PBMC, from
FRT cells expressing WT (C) or F508del-CFTR (D) and JA3 cells (E), were solubilized in
Laemmli SDS-PAGE loading solution, incubated at 37 °C for 30 min and submitted to
6% SDS-PAGE followed by immunoblotting. The arrows indicate the 170, 150 and
100 kDa CFTR forms detected using M3A7 mAb and the immunoreactive bands were
quantiﬁed as described in Materials and methods. The values are reported as the
arithmetic mean±SD. of three different experiments. The images are representative of
three different experiments.
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corresponded to the 100 kDa species, whereas the 170 kDa and
150 kDa forms were represented in very low amounts (Fig. 1D).
Finally, as shown in Fig. 1E, in JA3 cells both native and split CFTRwere
present, each one in an amount similar to that observed in circulating
normal PBMC, indicating that the 100 kDa form is produced in phy-
siological conditions.Fig. 2. Intracellular localization of different CFTR forms. (A) CFTR localization was determin
microscopy using M3A7 mAb (see Materials and methods). The images are representative
cells (1) or PBMC from control subjects (2) or CF patients (3), as described in Materials and
and methods). Membrane fractions were separately collected and the protein concentr
membranes and peak II contains plasma membranes: 5′-nucleotidase (5′-NT) activity was
were solubilized in Laemmli SDS-PAGE loading solution, incubated at 37 °C for 30 min and s
M3A7. (C) Aliquots (20 μg) of the total membrane fraction prepared for native electrophore
(lane 2) and CF patients (lane 3) were loaded on to a 0.8% agarose gel followed by immun
antibody (clone M3A7).3.2. Cellular localization of different CFTR forms
In Fig. 2A are reported the confocal microscope images establish-
ing the cellular localization of the different CFTR forms present in all
the cell types examined. In PBMC from healthy subjects (containing
both 170 kDa and 100 kDa CFTR forms) the CFTR-dependent ﬂuo-
rescence was present at the plasma membrane as well as throughouted in PBMC, in FRT cells expressing F508del and WT CFTR and in JA3 cells, by confocal
of six different experiments. (B) Total membrane fraction (0.5 ml) prepared from JA3
methods, was fractionated on a discontinuous sucrose density gradient (see Materials
ation was determined following the Lowry procedure. Peak I contains intracellular
assayed [51]. Aliquots (30 μl) of each sample of intracellular and plasma membranes
ubmitted to 6% SDS-PAGE, followed by immunoblotting. CFTR was detected using mAb
sis (see Materials and methods) from JA3 cells (lane 1) and PBMC from control subjects
oblotting as described in Materials and methods. CFTR was detected using the speciﬁc
Fig. 3. In vitro digestion of CFTR from FRT and JA3 cells by calpain. (A) The total
membrane fraction from FRT cells expressing wild type (5 μg) and F508del-CFTR
(20 μg) and from JA3 cells (20 μg) was incubated at 37 °C for 10 min in the presence of 1
unit of calpain and then submitted to 6% SDS-PAGE followed by immunoblotting. CFTR
was detected using mAbM3A7. (B) The total membrane fractions (20 μg) from JA3 cells
containing WT CFTR and from FRT cells expressing F508del-CFTR were incubated in the
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exclusively the 100 kDa CFTR form) the channel protein was almost
exclusively diffused into the cytoplasmic space. These ﬁndings
indicate that the mature 170 kDa CFTR form is localized at the
plasma membrane and that the ﬂuorescence signals of the digested
form become detectable in a punctate pattern through the cyto-
plasm, suggesting an association with the endomembrane system.
This conclusion received support by the confocal images of CFTR
expressed in FRT and in JA3 cells. In fact, in FRT cells expressing the
wild type channel form of 170 kDa, the protein was conﬁned almost
exclusively at the plasma membrane level, whereas in FRT cells
expressing the F508del-CFTR (in which the 100 kDa CFTR was the
predominant form) the ﬂuorescence, accordingly to previous obser-
vations [37], appeared to be diffused throughout the cell cytoplasm.
Moreover, in JA3 cells (in which the native and the digested 100 kDa
CFTR forms are both present) the protein channel was found to be
present both at the plasma membrane and within the cytoplasm. In
addition to confocal microscope analysis, the localization of the
different CFTR forms was further explored in isolated cell mem-
branes. To this purpose, total membrane fraction isolated from PBMC
of normal subjects and of CF patients was submitted to a sucrose
density gradient centrifugation previously set [24] to separate
plasma membranes from low density internal ER membranes. JA3
cell membranes were used as control [24]. As shown in Fig. 2B, the
170 kDa CFTR forms were exclusively present in the high density
fraction corresponding to plasma membrane, whereas the 100 kDa
CFTR species were detected in the low density membrane fraction.
Altogether these data are thus consistent with previous observa-
tions indicating that the 100 kDa form produced by calpain diges-
tion was recovered in the internal membrane vesicles [24].
Furthermore, since our observations suggested that the 100 kDa
CFTR species were the product of an intracellular limited proteolysis
exerted by calpain, we have explored if this protein was a discrete
form. We have found (Fig. 2C) that the charge–mass ratio of CFTR,
evaluated on total membrane fraction by electrophoresis in non-
denaturating conditions, was not modiﬁed by the presence of large
amounts of the 100 kDa species. This ﬁnding indicates that the
proteolytic split, occurring in CFTR molecule, produces a very limited
number of products which remains associated each other into the
membrane moiety.conditions described in (A) for the indicated times. The samples were subjected to
immunoblot analysis and CFTR was detected using mAb M3A7. The immunoreactive
bands, corresponding to Mr of 100 kDa and 170 kDa, were quantiﬁed as described in
Materials and methods.3.3. Susceptibility of F508del-CFTR to calpain digestion
All evidences so far presented indicated that both native and
mutated CFTR were digested by calpain and converted in a split form
identiﬁable as a 100 kDa protein. It remained to be established if the
Phe508 deletion altered the sensitivity of the chloride channel to
calpain. To this purpose, isolated total membrane fractions from both
FRT cells expressing wild type or F508del-CFTR forms and from JA3
cells were exposed to puriﬁed calpain and the changes in the
molecular properties of CFTR forms were evaluated in western blot
analysis. The data reported in Fig. 3 indicated that wild type 170 kDa
CFTR was totally converted and only partially recovered as the
100 kDa form. This ﬁnding can be explained by the observation that,
when this fragment was pre-existing in cell membranes, it was
degraded by the protease at lower rate (see JA3 cells). The digestion
pattern of F508del-CFTR resulted to be almost identical to that of
the wild type, suggesting that the deletion did not induce the for-
mation of different fragments. Addition of a synthetic calpain inhi-
bitor prevented proteolysis of all CFTR forms (data not shown), thus
excluding the involvement of contaminating plasma membrane
proteases. A comparative analysis of the in vitro digestion kinetics
(Fig. 3B) indicated that the rate of degradation of the F508del-CFTR
was very similar to that of the wild type form and the 100 kDa
fragment, generated from both CFTR forms, was more resistant tofurther degradation. The similar sensitivity to calpain digestion could
be explained by the fact that the cleavage site is not affected by the
Phe508 deletion.
In FRT cells expressing F508del-CFTR, Ca2+ loading (Fig. 4A) in-
duced a proteolytic digestion pattern identical to that observed in in
vitro conditions using isolated membranes exposed to puriﬁed
calpain. Intracellular involvement of calpain was further demonstrat-
ed by preloading cells with a permeable synthetic calpain inhibitor
(C.I.2) in which the proteolysis resulted to be completely prevented
(Fig. 4A). Identical effect was obtained using different calpain
inhibitors such as calpain inhibitor-1 (C.I.1), PD151746 and E-64
(data not shown). In spite of a similar sensitivity to calpain, when the
rate of degradation of the wild type and of the F508del-CFTR forms
was comparatively analyzed in intact Ca2+-loaded cells, it was
observed (Fig. 4B) that the 170 kDa F508del-CFTR was degraded
more rapidly than the wild type form. The digestion of the 100 kDa
fragment proceeded at a similar rate, being the two fragments
molecularly identical (Fig. 4C). Differently from the others CFTR
forms, the level of the immature 150 kDa species, was unaffected
following calpain activation (Fig. 4A).
Fig. 4. Effect of calpain activation on CFTR levels in JA3 cells and in FRT cells expressing
F508del-CFTR. (A) FRT cells (2 × 106) expressing F508del-CFTR were treated in culture
medium (seeMaterials andmethods) for 1 h at 37 °Cwith 1 μMCa2+-ionophore A23187
in the absence (Ca2+) or the presence of 1 μM C.I.2 (Ca2++C.I.2). Aliquots (40 μl) of the
total membrane fraction were solubilized in Laemmli SDS-PAGE loading solution,
incubated at 37 °C for 30 min and then submitted to 6% SDS-PAGE, followed by
immunoblotting. CFTR was detected using mAb M3A7 and the immunoreactive bands
were quantiﬁed as described in Materials and methods. The values are reported as the
arithmetic mean±SD of three different experiments. The images are representative of
three different experiments. (B and C) FRT cells (2 x 104) expressing F508del-CFTR or
JA3 cells (105) were incubated for 30 min at 37 °C in buffer B containing 50 μM t-Boc-
Leu-Met-CMAC ﬂuorogenic substrate. Cells were then washed and suspended in 100 μl
buffer B. Calpain activitywasmeasured after 10 min of cells exposure to 2 mMCaCl2 and
0.1 or 0.5 μM calcium ionophore A23187. Alternatively, the cells were pre-treated with
20 μM dibutyryl cAMP (see Materials and methods) and calpain activity was measured
after 10 min of exposure to 2 mM CaCl2 and 0.5 μM calcium ionophore A23187. In
parallel, the cells were treated in culture medium in the same conditions used for assay
intracellular calpain activity. Cells were then lysed and aliquots (20 μg) of the total
membrane fraction was solubilized in Laemmli SDS-PAGE loading solution and
submitted to SDS-PAGE 6%. Following immunoblotting, CFTR was detected with mAb
M3A7 and the immunoreactive bands corresponding toMr of 170 kDa and 100 kDawere
quantiﬁed as described inMaterials andmethods. The values reported are the arithmetic
mean±SD of three different experiments.
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The ﬁndings so far presented have indicated that in vitro the
sensitivity and the degradation pattern of the wild type and mutatedCFTR exposed to calpain are identical. However, in intact cells the
rate of digestion of the mutated 170 kDa channel protein was con-
siderably higher (see Fig. 4B). To explain this apparent discrepancy,
we analyzed the effect of association of HSP90 to F508del-CFTR on its
susceptibility to calpain digestion [24].
By means of density gradient centrifugation of total membrane
fraction from FRT cells expressing F508del-CFTR and JA3 cells, the
plasma membranes, containing exclusively the 170 kDa CFTR forms,
were separated from the low density membrane fraction, containing
the 100 kDa split form (see Fig. 2). Each solubilised membrane frac-
tion, containing comparable amounts of 170 and 100 kDa CFTR, was
then incubated with increasing concentrations of HSP90 and the
association of CFTR with the chaperone was determined by immuno-
precipitation. It was observed that (Fig. 5A), while the maximal
association between HSP90 and wild type 170 kDa CFTR occurred at a
concentration of the chaperone around 0.9 nM, the interaction with
170 kDa F508del-CFTR became detectable only at 3 nM HSP90 and
was maximal at 6 nM. Thus, Phe508 deletion promoted a decrease in
the afﬁnity of 170 kDa CFTR for the chaperone, approximately corre-
sponding to one order of magnitude. The same analysis, carried out on
solubilized membranes containing the split 100 kDa CFTR forms,
revealed that binding to HSP90 was not affected by the Phe508
deletion (Fig. 5B). To establish if the different afﬁnity to the chaperone
of the wild type and 170 kDa F508del-CFTR could thus be responsible
for their different sensitivity to calpain digestion, the two CFTR forms
were incubated with the protease in the presence of HSP90 (see
Fig. 5C). Whereas, the digestion of wild type 170 kDa CFTR was
completely prevented in the presence of 0.9 nM HSP90, the 170 kDa
F508del-CFTR digestion was approximately 40% reduced at 3 nM
HSP90 and 80% reduced at 6 nM. These results are in agreement with
those previously shown in Fig. 5A, indicating that the association to
HSP90 of the 170 kDa mutated channel protein is signiﬁcantly
reduced. As expected, the two split 100 kDa CFTR forms were both
protected from calpain digestion in the presence of 0.9 nM HSP90
(Fig. 5D). The protection of the protein channel, resulting from its
association to HSP90, suggests a novel role of the chaperone in the
preservation of functional CFTR at the plasma membrane.
3.5. Involvement of different proteolytic systems on the level and cellular
localization of CFTR
In order to establish how the calpain-mediated degradation of
F508del-CFTR could affect the level of plasma membrane chloride
channel, growing FRT cells expressing F508del-CFTR were exposed to
nontoxic amounts of C.I.2 [38]. For comparison, FRT cells were also
incubated with MG132, an inhibitor of proteasome activity. As shown
in Fig. 6, following 24 h (approximately two cell cycles) of expo-
sure to C.I.2, the level of the 170 kDa form at the plasma membrane
was 8- to 10-fold augmented, clearly demonstrating that the re-
duction of intracellular calpain activity favoured an increase in the
level of native 170 kDa CFTR recovered in its correct functional
localization. Similar results were obtained with other calpain
inhibitors (C.I.1 and PD151746), indicating that their effect was not
due to unspeciﬁc metabolic alterations (data not shown). It is inte-
resting to note that, in these conditions in which calpain activity
was reduced, the 100 kDa split form became undetectable, thus
conﬁrming previous results showing that the removal of the split
CFTR fragment requires the endosome–lysosome pathway rather than
the Ca2+-dependent protease activity [9,15,24]. In the presence of
MG132, no appreciable changes in the level of plasma membrane
F508del-CFTR were observed and no accumulation of the 100 kDa
form occurred. An increased ﬂuorescence diffused throughout the
cytoplasm indicated that these conditions favoured an accumulation
of the 150 kDa CFTR form that was trapped within the cell and that
proteasomal activity was not involved, in our experimental condi-
tions, in the removal of native F508del-CFTR from plasmamembranes.
Fig. 5. Interactions of WT and F508del-CFTR forms with HSP90. (A) Plasma membrane samples, isolated from JA3 cells and FRT cells expressing F508del-CFTR, containing
comparable amounts of 170 kDa WT and 170 kDa F508del-CFTR, evaluated on the basis of the intensity of their immunoreactive bands, were solubilized in 1% Triton® X-100 and
the indicated amounts of HSP90 were added to the suspensions. Immunoprecipitation was carried out using anti-CFTR mAb M3A7 (see Materials and methods). HSP90
co-immunoprecipitated with 170 kDa CFTR forms was detected by immunoblotting using the speciﬁc antibody and the immunoreactive bands were quantiﬁed as described in
Materials and methods. The values are reported as the arithmetic mean±SD of three different experiments. (B) The same immunoprecipitation described in (A) was performed
using intracellular membranes containing comparable amounts of 100 kDa WT and 100 kDa F508del-CFTR. HSP90 co-immunoprecipitated with 100 kDa CFTR forms was detected
by immunoblotting using the speciﬁc antibody and the immunoreactive bands were quantiﬁed and the values are reported as the arithmetic mean±SD of three different
experiments. Aliquots (20 μg) of plasma (C) and intracellular (D) membrane fraction, isolated from JA3 cells and FRT cells expressing F508del-CFTR, were incubated at 37 °C with
1 unit of calpain in the presence of the indicated amounts of HSP90. After 10 min, the incubations were stopped by the addition of Laemmli SDS-PAGE loading solution. The samples
were then incubated at 37 °C for 30 min and submitted to 6% SDS-PAGE, followed by immunoblotting. CFTR was detected using mAb M3A7. The immunoreactive bands
corresponding to 170 (C) and 100 (D) kDa CFTR forms were quantiﬁed and the values are reported as the arithmetic mean±SD of three different experiments. The images inserted
in each panel are representative of each experiment performed using respectively 0, 0.9 and 6 nM HSP90.
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such as Corr-4a, enhance maturation of F508del-CFTR by recovering
the interaction between the two halves of the channel [17–20]. In
order to explore if the effect of these compounds implied mecha-
nisms involving calpain activity, FRT cells expressing F508del-CFTR
were exposed to Corr-4a. In these conditions, a signiﬁcant increase in
the CFTR ﬂuorescence diffused in cytoplasm was presumably
attributable to the accumulation of large amounts of immature
150 kDa CFTR form. Since the level of 170 kDa CFTR at the plasma
membrane was increased less than 2-fold, it can be concluded that
the Corr-4a promoted a refolding of F508del-CFTR predominantly
accumulated in a still immature channel form unable to reach the
plasma membrane.
4. Discussion
The mechanisms responsible for the regulation of CFTR trafﬁcking
and for the delivery of the mature channel form at the apical
membrane level involve a multistep process which includes synthesis,
correct protein folding and maturation [4,5,39]. Furthermore, in order
to prevent cellular accumulation of misfolded proteins, nonnative
CFTR molecules are degraded by the ubiquitin proteasome system as
part of the ER-associated quality control [11,40]. It has also been
proposed that an additional peripheral quality control can remove, via
lysosomal degradation, unfolded plasma membrane-bound CFTR
molecules that have escaped the ER control [12–15]. Both mecha-
nisms are thus operating in the recognition and removal of misfolded
molecules in the course of the maturation of both the wild type
and F508del-CFTR, the most commonmutation of the channel protein
occurring in CF patients characterized by deletion of Phe508. However,
since the wild type CFTR molecules undergo predominantly a correctfolding, only a small fraction of unfolded molecules are degraded,
while most of them reach the plasma membrane. In the case of
F508del-CFTR, due to a folding defect, most of the protein is degraded
before reaching its functional location [41–43]. Different experimen-
tal approaches including inhibitors of ERAD or exposure to low
temperature (27 °C), being the conformational defect temperature-
sensitive, or alternatively treatment with small-molecule correctors,
were only partially effective in rescuing functional F508del-CFTR
which however, resulted to be highly instable and rapidly degraded
at 37 °C.
We have previously reported that, in growing cells, plasma
membrane CFTR, presumably as a part of its normal turnover,
undergoes degradation by calpain into a limited number of products
internalized into endosomal vesicles [24]. The experimental evidences
were the following: in the presence of calpain inhibitors no
degradation of CFTR occurred and no degradative products were
accumulated. Moreover, by immunoblotting analysis, using an
antibody directed against the C-terminal region of CFTR, both in
vitro and in vivo digestions were monitored by the appearance of a
100 kDa fragment. Based on the size of this fragment, the calpain
cleavage appeared to occur in a region between the NBD1 region and
the regulatory domain. Since in nondenaturating conditions both
native and cleaved CFTR form showed identical mass–charge ratio, the
proteolytic event did not promote the release of fragments from
cytoplasmic facing CFTR domain. Such 100 kDa product could be also
accumulated following exposure of native CFTR to trypsin [24],
indicating that CFTR contains a highly protease sensitive sequence,
possibly involved in determining the endocytic internalization.
Furthermore, the presence of high amounts of the 100 kDa fragment
was observed in PBMC of normal human subjects indicating that CFTR
degradation by calpain is a physiologically occurring process [24].
Fig. 6. Effect of different proteolytic systems on the level and localization of F508del-CFTR. FRT cells expressing F508del-CFTR were grown for 24 h in the absence (control) or
presence of 1 μM C.I.2 (+C.I.2), or 1 μM MG132 (+MG132), or 5 μM Corr-4a (+Corr-4a). Aliquots (50 × 104 cells) were lysed in 100 μl of Laemmli SDS-PAGE loading solution,
incubated at 37 °C for 30 min and 30 μl were submitted to 6% SDS-PAGE, followed by immunoblotting. The arrows indicate the 170, 150 and 100 kDa CFTR forms detected using
M3A7 mAb and the immunoreactive bands were quantiﬁed as described in Materials and methods. The values are reported as the arithmetic mean±SD of three different
experiments. The images are representative of three different experiments. For each treatment, intracellular CFTR localization was determined by confocal microscopy using M3A7
mAb and ﬂuorescence level was quantiﬁed (see Materials and methods) and reported as the arithmetic mean±SD of three different experiments. The images are representative
of three different experiments.
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to which a selective proteolysis of F508del-CFTR occurring at the
plasma membrane could be responsible for the very low level of the
mutated chloride channel, normally detectable in cells of CF patients.
A ﬁrst support to this hypothesis was provided by the ﬁndings,
herewith reported, that in lymphocytes from CF patients the 100 kDa
species were the almost only detectable form of CFTR, being the
170 kDa form present in negligible amounts.
We have also established that F508del-CFTR is cleaved by cal-
pain both in reconstructed system as well as in Ca2+-loaded cells
and that digestion produces the same fragments that are generated
following degradation by the protease of the wild type channel
protein form. However, in spite of a similar in vitro sensitivity to
calpain of the wild type and of the mutated CFTR, we have observed
that, in intact Ca2+-loaded cells, the 170 kDa F508del-CFTR was 3- to
5-fold more sensitive to digestion by the protease and thus degradedat a much faster rate. This higher susceptibility to calpain was due
to a lower capacity of the 170 kDa mutated channel protein to
interact with HSP90. Following the cleavage, the afﬁnity of F508del-
CFTR for the chaperone was fully recovered, thus explaining the
intracellular constitutive presence of high amounts of the 100 kDa
form. Consistently, in cells expressing F508del-CFTR, the cleaved
channel form, identiﬁed by the presence of the 100 kDa fragment,
was pre-existent in larger amounts than the 170 kDa form also
before Ca2+ loading and, furthermore, inhibition of intracellular
calpain activity during cell growth, resulted in a dramatic increase
(10-fold) of the 170 kDa form with the concomitant complete
disappearance of the cleaved CFTR form. Thus, calpain inhibition
promotes the rescue of signiﬁcant amounts of the mutated CFTR at
plasma membrane. Parallel experiments performed using Corr-4a
demonstrated that only a small amount of 170 kDa F508del-CFTR
reached the plasma membrane, whereas a large quantity of CFTR
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cytoplasmic localization. This large accumulation of the 150 kDa
CFTR is consistent with our previous observations indicating that
this form is resistant to intracellular calpain digestion [24]. Further-
more, since in these conditions the level of the 100 kDa remained
unchanged, it can be concluded that C.I.2 and Corr-4a operate at
different levels since the former promotes preferentially the accu-
mulation of CFTR at the plasma membrane and the latter that of the
channel protein in the course of its maturation at ER. The role of
calpain in the regulation of CFTR level at plasma membrane is further
indicated by the direct relationship observed between the extent
of CFTR degradation and intracellular activation of the protease.
Recent observations from different laboratories [44–46] indicate
that a number of membrane-associated protein channels are targets
of proteases, including calpains. Although, at present, a general role
of such proteolysis on the functions of these channels cannot be
deﬁned, it can be postulated that this limited proteolysis might be
involved in the regulation of the channels levels at the plasma
membrane as well as in the control of their transport efﬁciency.
In summary, our observations demonstrate that an enhanced
limited proteolysis by calpain of plasma membrane F508del-CFTR,
sustained by a decreased binding capacity for HSP90, contributes in
determining the very low level of the mutated channel at its
functional location. This degradation could be further enhanced by
the alteration of Ca2+ homeostasis reported to occur in CF epithelial
airway cells [23,47–50].
Altogether these ﬁndings suggest that the Ca2+-dependent pro-
teolysis can be regarded as a target for new therapeutic approaches
directed to ameliorate the life quality of CF patients. They can also
represent additional evidence in favour of a membrane localized
activity of calpain directed to degradation of transmembrane proteins
both in physiological and in pathological conditions such as those
herewith considered and more generally characterized in the so
called conformational diseases.
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